Cargando…
Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer
During tumorigenesis, certain tissues are colonized by mutant clones with oncogenic driver mutations as precancer lesions. These mutations can facilitate clonal expansion and may contribute to malignant transformation. The molecular features of low-grade non-muscle invasive bladder cancer (NMIBC) an...
Autores principales: | Hayashi, Yujiro, Fujita, Kazutoshi, Sakai, Kazuko, Adomi, Shogo, Banno, Eri, Nojima, Satoshi, Tomiyama, Eisuke, Matsushita, Makoto, Kato, Taigo, Hatano, Koji, Kawashima, Atsunari, Minami, Takafumi, Morii, Eiichi, Uemura, Hirotsugu, Nishio, Kazuto, Nonomura, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535027/ https://www.ncbi.nlm.nih.gov/pubmed/36198773 http://dx.doi.org/10.1038/s41598-022-21158-8 |
Ejemplares similares
-
TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer
por: Hayashi, Yujiro, et al.
Publicado: (2020) -
Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative review
por: Tomiyama, Eisuke, et al.
Publicado: (2022) -
Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study
por: Yamamoto, Akinaru, et al.
Publicado: (2022) -
Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma
por: Kato, Taigo, et al.
Publicado: (2021) -
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2020)